ACAD
34.62
-0.36
-1.03%
AEMD
4.89
-0.22
-4.3033%
APRI
0.353
+0.003
+0.9151%
ARNA
1.74
0.00
0.00%
ATEC
8.788
+0.158
+1.8331%
CNAT
2.03
-0.08
-3.79%
CRXM
0.22
-0.05
-18.52%
CYTX
2.12
0.00
0.00%
DXCM
93.06
-0.85
-0.91%
GNMK
11.59
-0.11
-0.94%
HALO
12.01
-0.08
-0.66%
ILMN
178.63
-0.7
-0.39%
INNV
0.28
0.00
0.00%
INO
9.54
+0.04
+0.42%
ISCO
1.9
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
114.27
-1.51
-1.30%
LPTN
3.96
+0.07
+1.80%
MBVX
4.6
-0.12
-2.54%
MEIP
1.73
+0.04
+2.3787%
MNOV
7.41
+0.31
+4.37%
MRTX
5.96
+0.08
+1.36%
MSTX
0.129
+0.001
+0.9419%
NBIX
53.26
-0.68
-1.26%
NUVA
66.58
-0.19
-0.28%
ONCS
1.778
-0.002
-0.112%
ONVO
3.94
-0.03
-0.76%
OREX
3.38
-0.08
-2.31%
OTIC
17.54
-0.11
-0.62%
QDEL
22.415
-0.295
-1.299%
RCPT
231.96
0.00
0.00%
RGLS
3.36
-0.09
-2.61%
RMD
63.51
+0.26
+0.41%
SPHS
3.037
+0.077
+2.5946%
SRNE
7.7
-0.07
-0.90%
TROV
4.745
-0.045
-0.9353%
VICL
3.21
-0.04
-1.23%
VOLC
18
0.00
0.00%
ZGNX
10.42
-0.03
-0.29%
ACAD
34.62
-0.36
-1.03%
AEMD
4.89
-0.22
-4.3033%
APRI
0.353
+0.003
+0.9151%
ARNA
1.74
0.00
0.00%
ATEC
8.788
+0.158
+1.8331%
CNAT
2.03
-0.08
-3.79%
CRXM
0.22
-0.05
-18.52%
CYTX
2.12
0.00
0.00%
DXCM
93.06
-0.85
-0.91%
GNMK
11.59
-0.11
-0.94%
HALO
12.01
-0.08
-0.66%
ILMN
178.63
-0.7
-0.39%
INNV
0.28
0.00
0.00%
INO
9.54
+0.04
+0.42%
ISCO
1.9
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
114.27
-1.51
-1.30%
LPTN
3.96
+0.07
+1.80%
MBVX
4.6
-0.12
-2.54%
MEIP
1.73
+0.04
+2.3787%
MNOV
7.41
+0.31
+4.37%
MRTX
5.96
+0.08
+1.36%
MSTX
0.129
+0.001
+0.9419%
NBIX
53.26
-0.68
-1.26%
NUVA
66.58
-0.19
-0.28%
ONCS
1.778
-0.002
-0.112%
ONVO
3.94
-0.03
-0.76%
OREX
3.38
-0.08
-2.31%
OTIC
17.54
-0.11
-0.62%
QDEL
22.415
-0.295
-1.299%
RCPT
231.96
0.00
0.00%
RGLS
3.36
-0.09
-2.61%
RMD
63.51
+0.26
+0.41%
SPHS
3.037
+0.077
+2.5946%
SRNE
7.7
-0.07
-0.90%
TROV
4.745
-0.045
-0.9353%
VICL
3.21
-0.04
-1.23%
VOLC
18
0.00
0.00%
ZGNX
10.42
-0.03
-0.29%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …